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TO THE EDITOR
Seborrheic keratoses (SKs) are among
the most common benign tumors in
humans, occurring in 80–100% of people
over 50 years of age (Yeatman et al.,
1997; Kwon et al., 2003). Although not
life-threatening, SKs may become irri-
tated and itchy, are often unattractive and
disfiguring, and may have a significantly
negative psychological impact as daily
reminders of aging. Several recent studies
of the pathogenesis of SK have identi-
fied the importance of somatic activating
mutations of fibroblast growth factor
receptor 3 (FGFR3) (Logie et al., 2005;
Hafner et al., 2006a, b, 2007a, b, c)
and oncogenic mutations of the p110a
subunit (PIK3CA) of phosphatidyl-
inositol 3-kinase (PI3K) in an indepen-
dent distribution (Hafner et al., 2007d,
2008).
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Figure 1. PTEN (phosphatase and tensin homolog deleted on chromosome 10) hemizygosity is a predisposing factor for skin tumorigenesis following UVA
irradiation. (a) Immunoblot analysis of PTEN protein levels in the epidermis from K14Cre;Ptenþ /þ (þ /þ ) and K14Cre;Ptenfl/þ (þ /) mice. (b) Percentage of
tumor-free mice (n¼ 15). (c) Incidence of seborrheic keratosis (SK) and squamous cell carcinoma (SCC). (d) A mouse with an SK (indicated by a red arrow)
developing in its skin. (e–h) Hematoxylin and eosin staining of the mouse specimens with SK and SCC. (e) SK at  2.5 magnification. (f) SK at original
magnification  10. (g) SCC at original magnification  10. (h) SCC at original magnification 10, with a smaller field of view. (e) Scale bar¼400 mm and
(f–h) scale bar¼100 mm. The green arrow in (h) indicates a multinucleated cell.
Abbreviations: AKT, a serine–threonine kinase, downstream of PI3K, also called protein kinase B; ERK,
extracellular signal-regulated kinase; PI3K, phosphoinositide 3-kinase; PTEN, phosphatase and tensin
homolog deleted on chromosome 10; SCC, squamous cell carcinoma; SK, seborrheic keratosis; þ /þ ,
Ptenþ /þ , K14Cre, Ptenþ /þ ; þ /, Ptenþ /, K14Cre, Ptenfl/þ
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At the molecular level, PI3K signal-
ing, upstream of AKT (a serine–threo-
nine kinase downstream of PI3K, also
called protein kinase B) activation,
is negatively regulated by the tumor
suppressor PTEN (phosphatase and ten-
sin homologue deleted on chromosome
10) (Di Cristofano and Pandolfi, 2000;
Suzuki et al., 2003; Backman et al.,
2004). Our recent studies demons-
trated that PTEN is downregulated by
exposure to both UVB (Ming et al.,
2010) and UVA (He et al., 2006).
Although SKs occur on both sun-
exposed and non-sun-exposed skin, cu-
mulative exposure to sunlight and aging
have been proposed as independent risk
factors for their development (Yeatman
et al., 1997; Kwon et al., 2003). Here we
report that in mice with a targeted PTEN
downregulation in their epidermis, UVA
causes the formation of tumors resem-
bling human SKs as well as of squamous
cell carcinomas (SCCs).
To determine the role of PTEN in
UVA-induced skin tumorigenesis, we
compared UVA-induced tumor forma-
tion between mice with normal PTEN
(þ /þ ) and mice with PTEN hemi-
zygosity (þ /). All animal procedures
were approved by the Institutional
Animal Care and Use Committee at the
University of Chicago. We deleted one
allele of the Pten gene in the epidermal
keratinocytes by crossbreeding mice
expressing Cre recombinase under the
control of the keratin 14 promoter
(K14-Cre) with mice expressing a LoxP-
flanked (floxed) Pten gene (Ptenfl/fl) to
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Figure 2. The PTEN (phosphatase and tensin homolog deleted on chromosome 10)/AKT (a serine–threonine kinase) pathway is involved in UVA-induced
tumorigenesis in Ptenþ /mice. (a–e) Immunohistochemical analysis of PTEN in nontumor and tumor samples using an anti-PTEN antibody. Scale bar¼50 mm.
(a, b) Sham-irradiated normal epidermis from (a) Ptenþ /þ and (b) Ptenþ / mouse. (c) UVA-irradiated nontumor epidermis, (d) seborrheic keratosis (SK),
and (e) squamous cell carcinoma (SCC) from Ptenþ / mouse. (f) Immunoblot analysis of PTEN, p-AKT (serine 473), AKT, and GAPDH (equal loading
control) in þ /þ , þ /, SK, and SCC. (g) Quantification of PTEN protein levels in (f). (h) Quantification of the ratio of p-AKT/AKT in (f). N in (g, h), normal
Ptenþ / skin. (i) Real-time RT-PCR analysis of the GLTSCR2 mRNA levels in þ /þ , þ /, and SK (n¼ 3). (j) Immunoblot analysis of p-AKT, AKT, p-ERK
(extracellular signal-regulated kinase), ERK, PTEN, and b-actin (equal loading control) in individual þ /þ and þ / mouse epidermis (n¼3) at 6
and 24 h post-UVA (15 J cm2). (k) Cell growth analysis of neonatal primary Ptenþ / keratinocytes infected with empty vector (EV) alone or wild-type
PTEN adenovirus (Ad-PTEN) at a multiplicity of infection of 50 at different times post sham or UVA irradiation (5 J cm2) (n¼3). The right panel shows
immunoblot analysis of PTEN and b-actin. Error bars show standard error (SE). (g, h) *Po0.05, significant difference between comparison groups. NS, not
statistically significant, P40.05. (k) *Po0.05, significant difference between sham-irradiated þ //EV and þ //Ad-PTEN groups. þ /þ , K14Cre;Ptenþ /þ ;
þ /, K14Cre;Ptenfl/þ ; EP, epidermis; D, dermis; HF, hair follicle; S, stroma; T, tumor.
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generate K14-Cre;Ptenfl/þ (Ptenþ /)
(Figure 1a). To mimic the scenario of
low-level UVA exposure that occurs in
daily life for most people, we deter-
mined that the maximal dose of UVA
that did not cause erythema was
15 J cm2 and used that dose for all
UVA experiments. The shaved mice
were exposed to UVA or protected from
UVA (sham group) for 25 weeks and
then monitored for tumor development.
In the absence of UVA, Ptenþ /þ
and Ptenþ / did not grow tumors
throughout the study period. UVA did
not cause tumor formation in Ptenþ /þ
mice. However, Ptenþ / mice began
to develop skin tumors at 37 weeks of
UVA irradiation (Figure 1b). A log-rank
test showed that PTEN hemizygosity
significantly accelerated skin tumori-
genesis following UVA irradiation
(Po0.0001). Histopathological analysis
of the tumors, using similar criteria for
mice (Logie et al., 2005; Benavides
et al., 2009), showed that in UVA-
exposed Ptenþ / mice 67% of the
tumors were of the SK type, whereas
33% were SCCs (Figure 1c and d).
Thus, following UVA radiation, PTEN
downregulation becomes a predispos-
ing factor for skin tumorigenesis. Simi-
lar to the transgenic mouse model with
an activating FGFR3 mutation (Logie
et al., 2005), the skin lesions observed
in our mouse model share several
histological features with human SKs,
including acanthosis, hyperkeratosis,
papillomatosis, and keratin-filled struc-
tures (horn cysts and pseudo–horn
cysts) (Figure 1e and f), while lacking
significant cytological atypia, whereas
the SCCs are characterized by the
presence of atypical nuclei, mitotic
figures, and multinucleated cells
(Figure 1g and h).
To determine the molecular mecha-
nisms by which UVA causes SK
and SCC in Ptenþ / mice, we carried
out immunohistochemical analysis of
sham-irradiated epidermis, UVA-irra-
diated nontumor epidermis, SK, and
SCC to investigate whether UVA
further reduces the PTEN dose during
tumorigenesis (Figure 2a and b). In
Ptenþ / epidermis, UVA irradiation
further reduced epidermal PTEN levels
(Figure 2c), consistent with our previous
findings (He et al., 2006). In SKs and
SCCs, PTEN levels were further reduced
as compared with nonlesional epider-
mis exposed to UVA or sham-irradiated
(Figure 2d and e). Immunoblot analysis
showed that PTEN was significantly
downregulated in both UVA-induced
SK and SCC (Figure 2f and g). As
compared with normal Ptenþ / skin,
AKT phosphorylation was significantly
increased in SK and SCC (Figure 2f and
h). However, there was no signifi-
cant difference in either PTEN or AKT
phosphorylation between SK and SCC
(Figure 2f–h). These findings suggest
that PTEN loss, in which UVA has an
active role, is an early event in the
development of SK and SCC.
To determine the mechanisms by
which UVA causes SK in Ptenþ /
mice, we examined the role of
the glioma tumor-suppressor candidate
region gene 2 (GLTSCR2), a nuclear
protein that binds to and stabilizes
PTEN (Okahara et al., 2004; Yim
et al., 2007) and is reduced in SK
(Kim et al., 2010). Real-time RT-PCR
analysis showed that there were no
significant differences in GLTSCR2
mRNA levels between þ /þ , þ /,
and SK (Figure 2i), suggesting that
GLTSCR2 is not involved in our SK
mouse model. To determine the mole-
cular impact of PTEN downregulation,
we examined the phosphorylation of
AKT and ERK (extracellular signal-regu-
lated kinase) in parental and PTEN-
downregulated epidermis. We found
that phosphorylation of AKT and ERK
in Ptenþ /þ skin was increased at 6
and 24 h after 15 J cm2 UVA irradia-
tion (Figure 2j and Supplementary
Figure S1 online). PTEN downregula-
tion significantly increased AKT phos-
phorylation at both 6 and 24 h
following 15 J cm2 UVA irradiation
(Figure 2j and Supplementary Figure
S1A online). However, it significantly
increased ERK phosphorylation only at
24 h following UVA irradiation (Figure
2j and Supplementary Figure S1B on-
line). Furthermore, we found that UVA
irradiation inhibited cell growth in vitro
and in vivo (Figure 2k and Supplemen-
tary Figure S2 online). Constitutive
PTEN reduction in the epidermis de-
layed cell exit from UVA-induced
growth arrest (Supplementary Figure
S2 online). While acute re-expression
of PTEN in PTENþ / keratinocytes
had little effect on cell growth post-
UVA irradiation in vitro, it significantly
inhibited cell growth in sham-irradiated
cells (Po0.05) (Figure 2k). These data
indicate that PTEN reduction exerts a
critical role in UVA-induced develop-
ment of SK as well as SCC, probably
through the AKT and ERK pathways.
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